Use of a personalized phenytoin dosing approach to manage difficult to control seizures in an infant with a SCN2A mutation
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Ziesenitz, Victoria C.
van den Anker, Johannes N.
Text and Data Mining valid from 2019-01-15
27 November 2018
3 January 2019
15 January 2019
Compliance with ethical standards
The authors declare that they have no conflict of interest